MedTrace Logo

Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy

NCT06513585 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 570

Last updated 2025-04-15

No results posted yet for this study

Summary

The aim of this study was to compare the efficacy and safety of adrenalectomy and superselective adrenal artery embolization in a prospective, multicenter, randomized controlled study. To provide a new interventional alternative therapy for primary aldosteronism.

Conditions

  • Primary Aldosteronism
  • Suprarenalectomy
  • Super Selective Adrenal Artery Embolization

Interventions

PROCEDURE

Superselective adrenal artery embolization or adrenalectomy

Arm A underwent SAAE treatment, and arm B underwent laparoscopic adrenalectomy.

Sponsors & Collaborators

  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER

  • Xinjiang Medical University

    lead OTHER

Principal Investigators

  • Ying-Ying Zheng, PhD · 1st affiliatted hospital of Xinjiang Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-05-01
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06513585 on ClinicalTrials.gov